ATE357442T1 - Verfahren zur herstellung von candesartan cilexetil - Google Patents

Verfahren zur herstellung von candesartan cilexetil

Info

Publication number
ATE357442T1
ATE357442T1 AT04795674T AT04795674T ATE357442T1 AT E357442 T1 ATE357442 T1 AT E357442T1 AT 04795674 T AT04795674 T AT 04795674T AT 04795674 T AT04795674 T AT 04795674T AT E357442 T1 ATE357442 T1 AT E357442T1
Authority
AT
Austria
Prior art keywords
candesartan cilexetil
cilexetil
reaction
producing
producing candesartan
Prior art date
Application number
AT04795674T
Other languages
English (en)
Inventor
Marina Yu Etinger
Boris Fedotev
Ben-Zion Dolitzky
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34468494&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE357442(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Teva Pharma filed Critical Teva Pharma
Application granted granted Critical
Publication of ATE357442T1 publication Critical patent/ATE357442T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT04795674T 2003-10-16 2004-10-18 Verfahren zur herstellung von candesartan cilexetil ATE357442T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US51256603P 2003-10-16 2003-10-16
US52352403P 2003-11-18 2003-11-18
US53799504P 2004-01-21 2004-01-21
US56864904P 2004-05-05 2004-05-05

Publications (1)

Publication Number Publication Date
ATE357442T1 true ATE357442T1 (de) 2007-04-15

Family

ID=34468494

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04795674T ATE357442T1 (de) 2003-10-16 2004-10-18 Verfahren zur herstellung von candesartan cilexetil

Country Status (9)

Country Link
US (2) US7098342B2 (de)
EP (1) EP1685126B1 (de)
AT (1) ATE357442T1 (de)
CA (1) CA2542499A1 (de)
DE (1) DE602004005488T2 (de)
ES (1) ES2284068T3 (de)
IL (1) IL174868A0 (de)
PT (1) PT1685126E (de)
WO (1) WO2005037821A2 (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005077941A2 (en) * 2004-02-11 2005-08-25 Teva Pharmaceutical Industries Ltd. Candesartan cilexetil polymorphs
KR20070088783A (ko) * 2005-01-14 2007-08-29 테바 파마슈티컬 인더스트리즈 리미티드 조 칸데사르탄 실렉세틸의 제조
CN100400536C (zh) * 2005-04-30 2008-07-09 重庆圣华曦药业有限公司 坎地沙坦酯c-型晶体的制备方法
WO2007074399A2 (en) * 2005-06-06 2007-07-05 Medichem, S.A. Process for the preparation of tetrazolyl compounds
SI22127A (sl) * 2005-10-07 2007-04-30 Krka, Tovarna Zdravil, D.D., Novo Mesto Postopek za pripravo kandesartan cileksetila
CZ302240B6 (cs) * 2006-03-16 2011-01-05 Zentiva, A. S Zpusob odstranování trifenylmethanové chránicí skupiny u prekursoru antihypertensiv majících labilní, metabolicky odbouratelnou skupinu
WO2008012371A1 (en) * 2006-07-28 2008-01-31 Krka, Tovarna Zdravil, D.D., Novo Mesto Process for the preparation of amorphous and crystalline forms of candesartan cilexetil using column chromatography
KR100995755B1 (ko) 2008-10-31 2010-11-19 일동제약주식회사 트리틸 칸데사르탄 실렉세틸의 개선된 제조방법
WO2011080684A1 (en) 2009-12-31 2011-07-07 Ranbaxy Laboratories Limited Process for the preparation of candesartan cilexetil
WO2011092666A1 (en) 2010-01-29 2011-08-04 Ranbaxy Laboratories Limited An improved process for the preparation of candesartan cilexetil, polymorphic forms of n-trityl candesartan and their uses thereof

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4151273A (en) * 1974-10-31 1979-04-24 The Regents Of The University Of California Increasing the absorption rate of insoluble drugs
FR2408345A1 (fr) * 1976-11-30 1979-06-08 Besins Jean Louis Nouvelle composition a action anti-conceptionnelle
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
SE457326B (sv) * 1986-02-14 1988-12-19 Lejus Medical Ab Foerfarande foer framstaellning av en snabbt soenderfallande kaerna innehaallande bl a mikrokristallin cellulosa
IL95975A (en) * 1989-10-24 1997-06-10 Takeda Chemical Industries Ltd N-benzyl- 2-alkylbenzimidazole derivatives, their production and pharmaceutical compositions containing them
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5703110A (en) * 1990-04-27 1997-12-30 Takeda Chemical Industries, Ltd. Benzimidazole derivatives, their production and use
US6004989A (en) * 1990-04-27 1999-12-21 Takeda Chemical Industries, Ltd. Benzimidazole derivatives, their production and use
RU1836357C (ru) * 1990-07-23 1993-08-23 Др.Карл Томэ ГмбХ Производные бензимидазола, их изомеры, смеси изомеров, гидраты или их физиологически переносимые соли, обладающие антагонистическими в отношении ангиотензина свойствами
DE4023369A1 (de) * 1990-07-23 1992-01-30 Thomae Gmbh Dr K Benzimidazole, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
US5210206A (en) * 1990-09-10 1993-05-11 Abbott Laboratories 1,3-oxazolyl substituted biphenyl
US5145684A (en) * 1991-01-25 1992-09-08 Sterling Drug Inc. Surface modified drug nanoparticles
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations
TW284688B (de) * 1991-11-20 1996-09-01 Takeda Pharm Industry Co Ltd
EP0550313A1 (de) * 1991-12-30 1993-07-07 Synthelabo 2-(Tetranol-5-yl)-(1,1'-Biphenyl)derivate, ihre Herstellung und Anwendung als Zwischenverbindungen
AU679465B2 (en) * 1992-10-14 1997-07-03 Unilever Plc Salad dressing
US5281604A (en) * 1993-04-23 1994-01-25 American Cyanamid Company Angiotensin II receptor blocking 2,3,6-substituted quinazolinones
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
US5298517A (en) * 1993-10-07 1994-03-29 American Cyanamid Company Angiotensin II receptor blocking agents
EP0668272B1 (de) * 1994-01-28 2000-07-12 Takeda Chemical Industries, Ltd. Ein Verfahren zur Herstellung von Tetrazolyl-Verbindungen
US6177587B1 (en) 1997-05-26 2001-01-23 Takeda Chemical Industries, Ltd. Production method of aminobenzene compound
SE9901667D0 (sv) * 1999-05-07 1999-05-07 Astra Ab Method and device for forming particles
CA2453890A1 (en) 2001-08-03 2003-02-20 Takeda Chemical Industries, Ltd. Crystal and process for producing the same
EP1835890A2 (de) * 2005-01-06 2007-09-26 Elan Pharma International Limited Candesartan-nanopartikelformulierungen

Also Published As

Publication number Publication date
US7098342B2 (en) 2006-08-29
WO2005037821A2 (en) 2005-04-28
IL174868A0 (en) 2006-08-20
PT1685126E (pt) 2007-04-30
ES2284068T3 (es) 2007-11-01
CA2542499A1 (en) 2005-04-28
US20060252939A1 (en) 2006-11-09
DE602004005488T2 (de) 2007-11-29
EP1685126A2 (de) 2006-08-02
US20050131037A1 (en) 2005-06-16
WO2005037821A3 (en) 2005-06-02
DE602004005488D1 (de) 2007-05-03
EP1685126B1 (de) 2007-03-21

Similar Documents

Publication Publication Date Title
DE602005011308D1 (de) Substituierte organopolysiloxane und ihre verwendung
NO20081269L (no) Utvidbare metadata
ATE357442T1 (de) Verfahren zur herstellung von candesartan cilexetil
EA201170022A1 (ru) Гидрирование алканов, содержащих более одного атома брома
DE502005002316D1 (de) Arylsubstituierte polycyclische amine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
ATE517094T1 (de) Verfahren zur herstellung von medetomidin und seinen salzen
TW200602387A (en) A polymer and a process for producing the same
ATE348609T1 (de) Tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer
ATE398121T1 (de) Neue synthese von irbesartan
BR0312263A (pt) Sistema catalìtico, bem como polìmero e processo de polimerização empregando o referido sistema
DE602004001383D1 (de) Gasgenerator
TW200510347A (en) Process for organic compounds
ATE344228T1 (de) Verfahren zur herstellung von ethylenaminen
ATE554063T1 (de) Verfahren zur herstellung von ketonen aus alpha- oxocarboxylaten und arylbromiden
TW200720238A (en) Intramolecular prins reaction and catalysts suitable therefor (citronellall to isopulegol)
ATE525364T1 (de) Verfahren zur herstellung von 3,6-dihydro-1,3,5- triazin-derivaten
ATE513801T1 (de) Verfahren zur synthese von propargylatierten aminoindanderivativen
ATE504554T1 (de) Verfahren zur substitution von indenofluorenen
DE502004003023D1 (de) Gasgenerator
ATE397579T1 (de) Verfahren zur herstellung von 2,3,5- trimethylhydrochinondiacylaten
DK1737807T3 (da) Fremgangsmåde til fremstilling af 1-acetyl-1-chlorcyclopropan
DE602005021640D1 (de) Verfahren zur umwandlung von ethylen in propylen
EP1867390A4 (de) Verfahren zur verarbeitung von schwefelwasserstoff, verfahren zur herstellung von wasserstoff und photokatalysatorreaktor
ATE252589T1 (de) Aluminosiloxanverbindungen und verfahren zu ihrer herstellung
ATE384069T1 (de) Alkyliden-tetrahydronaphthalinderivate, verfahren zu ihrer herstellung und ihre verwendung als entzündungshemmer

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties